In this context, members of the EGF receptor family have emerged as promising targets in the treatment of various forms of cancer, due to their fundamental involvement in the activation of the proliferation and survival pathway induced by the PI3K / AKT pathway [7]. The gene discussed is AKT1; the disease is cancer.